Latest AI Startup Funding Rounds
Funding for companies building AI models, tools and applications. Explore the products, customers and businesses attracting capital.
- Rounds
- 2,365 Jan 1 – Oct 22, 2026
- Disclosed funding
- $203.5B 2002 disclosed amounts
- Median round
- $15M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| EC Efficient ComputerCompany profile Efficient Computer develops general-purpose data-flow processors and software tools for computing and AI systems. Efficient Computer develops general-purpose data-flow processors and software tools for computing and AI systems. | $60M | Series A | AI, Hardware | United States | Investors | |
| SP Develops next-generation peptide radioligand therapies for cancer | $18M | Series A | AI, Biotech | United States | Investors | |
| PS ProSomnus Sleep TechnologiesCompany profile Provides non-CPAP alternative for Obstructive Sleep Apnea treatment Provides non-CPAP alternative for Obstructive Sleep Apnea treatment | $38M | StrategicUndisclosed | AI, Healthtech | United States | Investors | |
| O OnshoreCompany profile Builds AI-powered platform to help businesses claim and defend tax incentives like R&D credits with automation and expert review Builds AI-powered platform to help businesses claim and defend tax incentives like R&D credits with automation and expert review | $31M | Series B | AI, Fintech | United States | Investors | |
| V Provides infrastructure platform powering America's modern savings economy | $385M | Series ESeries C+ | AI, Fintech | United States | Investors | |
| CS Cogent SecurityCompany profile Builds autonomous AI agents to automate vulnerability remediation for security teams Builds autonomous AI agents to automate vulnerability remediation for security teams | $42M | Series A | AI, Cybersecurity | United States | Investors | |
| P Pharmacelera uses quantum-mechanics methods and AI in drug discovery. | €6M | Growth | AI, Biotech | Spain | Investors | |
| SB Sift BiosciencesCompany profile Develops next-generation peptide immunotherapy platform using AI metagenomics and high-throughput profiling to engage memory T cells for cancer and autoimmune diseases Develops next-generation peptide immunotherapy platform using AI metagenomics and high-throughput profiling to engage memory T cells for cancer and autoimmune diseases | $3.7M | Pre-SeedPre-seed | AI, Biotech | United States | Investors | |
| A Provides AI-native operating system for financial services firms | $35M | Series A | AI, Fintech | United States | Investors | |
| Z Builds AI agent for software reverse engineering | Undisclosed | Pre-SeedPre-seed | AI, Cybersecurity | Israel | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Greptile, Nous Research, Halluminate
106rounds2led - 2General Catalyst
Legora, Different, Baba
78rounds6led - 3Andreessen Horowitz (a16z)
Eka Robotics, Town, Labelbox
78rounds14led - 4Lightspeed
Warp Sciences, Different, Zenzap
67rounds7led - 5Accel
Legora, RapidCanvas, Modal Labs
53rounds5led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.